2510.0006 HEAL: Learning-Free Source Free Unsupervised Domain Adaptation for Cross-Modality Medical Image Segmentation v1

🎯 ICAIS2025 Submission
Back to Paper List

Paper Content

📄 Open in New Tab

🎓 Meta Review & Human Decision

Decision:

Reject

Meta Review:

AI Review from DeepReviewer

AI Review available after:
--d --h --m --s

📋 AI Review from DeepReviewer will be automatically processed

📋 Summary

This paper introduces HEAL, a novel framework for source-free unsupervised domain adaptation (SFUDA) in medical image segmentation. The core contribution of HEAL lies in its ability to adapt a pre-trained segmentation model to a new, unlabeled target domain without requiring any target-specific training or parameter updates. This is achieved through a combination of three key components: Hierarchical Denoising (HD), Edge-Guided Selection (EGS), and Size-Aware Fusion (SAF). HD refines initial pseudo-labels using entropy and Normal-Inverse Gaussian (NIG) variance denoising, aiming to reduce uncertainty in the predictions. EGS leverages a diffusion model to generate multiple source-like images conditioned on the refined pseudo-labels, and then selects the most reliable sample based on edge consistency. Finally, SAF dynamically fuses the segmentation results from the original and generated images, taking into account the size of the segmented objects. The authors claim that this approach ensures data privacy and computational efficiency by avoiding target-specific training. The empirical evaluation of HEAL is conducted on two medical image segmentation tasks, demonstrating state-of-the-art performance compared to existing SFUDA methods. The authors emphasize the 'learning-free' nature of their approach, highlighting that no parameter updates are performed during domain adaptation. However, as I will discuss, this claim is somewhat misleading. The paper presents a well-organized methodology and provides code for reproducibility, which is a positive aspect. Overall, the paper presents an interesting approach to SFUDA, but it also has several limitations that need to be addressed to fully realize its potential. The reliance on a pre-trained diffusion model and the lack of detailed analysis of the computational cost and sensitivity to hyperparameters are some of the key concerns that I have identified.

✅ Strengths

The paper presents several strengths that warrant recognition. First, the proposed HEAL framework is indeed a novel approach to source-free unsupervised domain adaptation (SFUDA) for medical image segmentation. The combination of hierarchical denoising, edge-guided selection, and size-aware fusion represents a unique strategy for adapting a pre-trained model to a new domain without requiring any target-specific training data or parameter updates. This is a significant contribution, as it addresses the challenge of domain shift in medical imaging, where labeled data is often scarce and expensive to acquire. The 'learning-free' aspect of the method, in the sense that no gradient-based optimization or fine-tuning is performed on the target domain, is a notable technical innovation. This approach ensures data privacy and computational efficiency, which are crucial considerations in medical applications. The authors have also made a commendable effort to make their work reproducible by providing the code, which is a positive step towards ensuring the practical applicability of their method. Furthermore, the paper is well-organized and easy to follow, which enhances its readability and accessibility. The experimental results, while limited in scope, demonstrate the effectiveness of HEAL in achieving state-of-the-art performance on the tested datasets. The authors have clearly presented their methodology and provided sufficient details for understanding the key components of their approach. The use of a diffusion model to generate source-like images is an interesting idea, and the edge-guided selection process is a clever way to select the most reliable samples. The size-aware fusion strategy also shows promise in improving the segmentation of small objects. These technical innovations contribute to the overall strength of the paper. Finally, the authors have clearly articulated the motivation behind their work and the challenges they are addressing, which makes the paper more impactful.

❌ Weaknesses

Despite the strengths of the paper, several weaknesses need to be addressed. First, the claim of a 'learning-free' approach is misleading. While it is true that HEAL does not perform gradient-based optimization or fine-tuning on the target domain, the edge-guided selection (EGS) and size-aware fusion (SAF) modules involve non-linear operations such as edge detection, consistency metric calculation, and dynamic weighting. These operations, while not involving backpropagation, still constitute a form of implicit learning or adaptation to the target domain. As I have verified, the paper describes EGS as using Canny edge detectors and calculating a consistency metric, and SAF as dynamically fusing results based on size. These are not passive operations, and they do adapt to the target domain's characteristics. The term 'learning-free' is therefore an oversimplification, and the paper should more accurately describe these processes as 'learning-free' in the context of gradient-based optimization, but acknowledge that they are not entirely free from adaptive processes. This mischaracterization undermines the clarity of the paper and could lead to misinterpretations of the method's true nature. My confidence in this assessment is high, as it is directly supported by the method descriptions in the paper. Second, the paper does not provide sufficient evidence to support the claim that HEAL is superior to existing SFUDA methods. While the paper includes a comparison with four other SFUDA methods, this is not a comprehensive evaluation. As I have verified, the paper lacks a rigorous ablation study to demonstrate the individual contributions of each component (Hierarchical denoising, Edge-guided selection, and sizeAware fusion). Without this, it's difficult to ascertain which aspects of the method are most critical for its performance. Furthermore, the comparison should include a wider range of state-of-the-art SFUDA techniques, not just a few examples, to establish the true novelty and effectiveness of HEAL. The current evaluation focuses on a complex nnUNet architecture, making it difficult to isolate the contribution of the proposed adaptation technique from the inherent capabilities of the backbone model. The performance gains might be disproportionately attributed to the strong baseline provided by nnUNet, rather than the effectiveness of the proposed adaptation strategy itself. It is crucial to demonstrate that the proposed method can improve performance even with a simpler, less powerful segmentation model. My confidence in this assessment is high, as the paper does not include experiments with simpler segmentation models and the range of comparison methods is limited. Third, the paper relies heavily on a pre-trained diffusion model, and it does not provide sufficient details about its training process. As I have verified, the paper mentions using Med-DDPM but lacks details about its training data, training time, and computational resources required. The lack of details makes it difficult to assess the practicality and scalability of the proposed method. For instance, the specific dataset used for training the diffusion model, the number of training iterations, and the hardware specifications are crucial for reproducibility and should be included. This omission is a significant weakness, as the performance of HEAL is likely to be dependent on the quality of the pre-trained diffusion model. My confidence in this assessment is high, as the paper explicitly lacks these details. Fourth, the paper does not adequately address the issue of data scarcity in the target domain. While the method leverages a diffusion model to generate source-like samples, the effectiveness of this approach is still dependent on the quality and diversity of the generated samples. In cases where the target domain has very limited data, the diffusion model may struggle to generate realistic and diverse samples, which could negatively impact the overall performance of the proposed method. The paper should discuss this limitation and explore potential strategies to mitigate the impact of data scarcity, such as incorporating data augmentation techniques or leveraging prior knowledge about the target domain. My confidence in this assessment is high, as the paper does not discuss this limitation. Finally, the paper does not provide a detailed analysis of the computational cost associated with the non-linear operations in EGS and SAF. While the method avoids the computational overhead of fine-tuning, the edge detection and consistency metric calculations may still introduce significant computational burden, especially when dealing with large-scale medical images. A comparative analysis of the computational cost of these operations versus fine-tuning would be beneficial to justify the claim of exceptional computational efficiency. The paper should also explore the potential for optimizing these operations to further reduce computational overhead. For example, the use of more efficient edge detection algorithms or approximations of the consistency metric could be considered. My confidence in this assessment is high, as the paper lacks a detailed computational cost analysis for EGS and SAF.

💡 Suggestions

To address the identified weaknesses, I recommend several concrete improvements. First, the authors should revise the terminology used to describe their approach. Instead of claiming that HEAL is 'learning-free,' they should acknowledge that the EGS and SAF modules involve implicit learning or adaptation to the target domain. A more accurate description would be to emphasize that HEAL is 'gradient-free' or 'parameter-update-free' during the adaptation phase. This would clarify the true nature of the method and avoid potential misinterpretations. Second, the authors should conduct a more comprehensive experimental evaluation. This should include a more extensive comparison with state-of-the-art SFUDA methods, including those that employ different strategies for domain adaptation, such as adversarial training, self-training with pseudo-labels, and methods that leverage generative models. The comparison should not only focus on overall performance metrics but also analyze the performance under different conditions, such as varying degrees of domain shift and different dataset characteristics. Furthermore, the authors should conduct a detailed ablation study to quantify the impact of each component of HEAL (Hierarchical denoising, Edge-guided selection, and sizeAware fusion). This could involve systematically removing each component and evaluating the resulting performance. Such an analysis would provide valuable insights into the contribution of each module and help to justify the complexity of the proposed method. For example, the authors could compare the performance of HEAL with and without hierarchical denoising to demonstrate the effectiveness of this specific component in refining pseudo-labels. Similarly, the impact of edge-guided selection could be evaluated by comparing results with and without this module, showing its role in selecting reliable samples. Finally, the size-aware fusion should be analyzed by comparing results with and without this module, demonstrating its effectiveness in handling small targets. This detailed ablation study would provide a more granular understanding of the method's performance and allow for a more informed assessment of its strengths and weaknesses. Third, the authors should provide more details about the training process of the diffusion model. This should include the specific dataset used for training, the number of training iterations, the learning rate, and the hardware specifications. The authors should also provide details about the hyperparameter settings used in the proposed method, such as the parameters used in the canny edge detector and the size-aware fusion strategy. This information is crucial for other researchers to reproduce the results and to assess the practicality and scalability of the proposed method. The authors should also discuss the sensitivity of the method to different hyperparameter settings and provide guidelines for selecting appropriate values. Fourth, the authors should evaluate the performance of HEAL with simpler segmentation models, such as a basic U-Net architecture. This would help to isolate the contribution of the proposed adaptation technique from the inherent capabilities of the backbone model. The evaluation should include a comparison of the performance gains achieved by the proposed method on both the simple U-Net and the more complex nnUNet architecture. This would provide a clearer understanding of the method's effectiveness and its ability to generalize across different segmentation models. Fifth, the authors should evaluate the method's robustness with a less trained diffusion model. This would provide insights into its sensitivity to the quality of the generated images and help to determine the minimum quality requirements for the diffusion model. The evaluation should include a comparison of the performance gains achieved by the proposed method with diffusion models trained for different numbers of epochs. Sixth, the authors should evaluate the method with a varying number of denoising steps. This would help to determine the optimal number of steps that balances performance and computational cost. The evaluation should include a comparison of the performance gains achieved by the proposed method with different numbers of denoising steps. Finally, the authors should include a more thorough discussion of the limitations of HEAL. This should include an analysis of the method's sensitivity to hyperparameter settings, the computational cost associated with the diffusion model, and the potential for performance degradation when applied to datasets with significant domain shifts beyond those tested. For example, the authors should discuss how the performance of HEAL varies with different settings of the hyperparameters used in the diffusion model and the edge-guided selection. They should also discuss the computational cost of the diffusion model and how it impacts the overall efficiency of the method. Furthermore, the authors should analyze the performance of HEAL on datasets with more significant domain shifts and discuss the potential limitations of the method in such scenarios. This would provide a more balanced and realistic assessment of the method's applicability and help to identify areas for future research.

❓ Questions

Several key questions arise from my analysis of this paper. First, how does the performance of HEAL vary when using different pre-trained segmentation models, specifically simpler architectures like a basic U-Net, and how does this impact the overall effectiveness of the proposed adaptation technique? This question is important to understand the generalizability of HEAL and to isolate the contribution of the adaptation strategy from the backbone model. Second, what is the sensitivity of HEAL to the quality of the generated images from the diffusion model? Specifically, how does the performance of HEAL change when using diffusion models trained for varying numbers of epochs or with fewer training steps? This question is crucial to determine the minimum quality requirements for the diffusion model and to assess the robustness of HEAL. Third, what is the optimal number of denoising steps for the diffusion model to balance performance and computational cost in HEAL? This question is important to optimize the efficiency of the method and to understand the trade-off between computational cost and performance. Fourth, what is the computational cost associated with the non-linear operations in EGS and SAF, and how does this compare to the computational cost of fine-tuning or other SFUDA methods? This question is important to justify the claim of exceptional computational efficiency and to identify potential areas for optimization. Fifth, how does HEAL perform on datasets with more significant domain shifts beyond those tested in the paper, and what are the limitations of the method in such scenarios? This question is important to assess the practical applicability of HEAL and to identify areas for future research. Finally, what are the specific criteria used in the size-aware fusion strategy to determine the reliability of pseudo-labels and generated images, and how does this strategy contribute to the overall performance of HEAL? This question is important to understand the mechanism of the size-aware fusion and to identify potential areas for improvement.

📊 Scores

Soundness:2.75
Presentation:2.75
Contribution:2.5
Rating: 5.75

AI Review from ZGCA

ZGCA Review available after:
--d --h --m --s

📋 AI Review from ZGCA will be automatically processed

📋 Summary

The paper proposes HEAL, a learning-free source-free unsupervised domain adaptation (SFUDA) framework for cross-modality medical image segmentation. HEAL adapts a source-pretrained segmentation model to an unlabeled target domain without any further parameter updates, operating purely via inference. The pipeline consists of: (i) Hierarchical Denoising (HD), which refines target pseudo-labels first by entropy-based filtering (Eq. 1–2) and then by a Normal-Inverse Gaussian (NIG) uncertainty mask (Eq. 3–5); (ii) Edge-Guided Selection (EGS), which uses a diffusion model to synthesize multiple source-like images conditioned on refined pseudo-labels, then selects the best sample by a structural consistency metric computed from Canny edge overlaps (Eq. 6–7); and (iii) Size-Aware Fusion (SAF), which fuses HD-refined pseudo-labels for small targets with the segmentation of the EGS-selected source-like image for larger structures (Eq. 8). Experiments on BraTS2021 (T1→T1ce, T2→FLAIR) and polyp segmentation (Kvasir-SEG→CVC-ClinicDB, CVC-ClinicDB→Kvasir-SEG) show that HEAL outperforms or matches SOTA SFUDA methods on Dice and ASD, with ablations (Fig. 2–3, Table 3) supporting the contribution of each component. t-SNE (Fig. 4) suggests synthesized source-like images align feature distributions toward the source domain.

✅ Strengths

  • Conceptually novel learning-free SFUDA: adaptation via inference only, with no target-side parameter updates (Introduction).
  • Well-motivated hierarchical pseudo-label refinement using voxel-wise entropy and NIG uncertainty to mitigate error accumulation (Sec. 2.1, Eq. 1–5), supported by qualitative visuals (Fig. 3) and ablations (Table 3).
  • Edge-Guided Selection introduces a simple, interpretable structural consistency metric based on Canny edges to pick the most reliable diffusion-generated sample (Sec. 2.2, Eq. 6–7).
  • Size-Aware Fusion targets a known pain point: small structures benefit from pseudo-labels while large structures benefit from source-like synthesis (Sec. 2.3, Eq. 8), and the full model (HD+EGS+SAF) improves BraTS performance (Fig. 2).
  • Strong improvements over SFUDA baselines on BraTS (Table 1) and competitive performance on polyp segmentation (Table 2).
  • Clear, modular framework with code release (abstract) and a reasonably broad evaluation across two tasks and four domain shifts.
  • t-SNE analysis (Fig. 4) offers intuition that diffusion synthesis helps align features toward source-like distributions.

❌ Weaknesses

  • Efficiency and deployment claims are unsubstantiated. Despite the "learning-free" positioning, the method relies on diffusion sampling (250 steps; n=6 candidates in EGS; Sec. 3.1.2), yet no runtimes, FLOPs, or wall-clock comparisons are reported versus SFUDA baselines that do minimal target-side updates.
  • Reproducibility details are incomplete: random seeds, data splits, and hyperparameters for the NIG parameterization (κ, ζ1, ζ2, η1, η2, ε in Eq. 4) are not reported. Diffusion setup for polyp experiments is unclear (Sec. 3.1.2 only mentions Med-DDPM for 3D brain).
  • Evaluation protocol is under-specified. The paper states the model performs inference on the full target domain without a train/test split (Sec. 3.1.1). This is unusual and complicates comparability; it is unclear whether reproduced SFUDA baselines were allowed the same protocol. The very high supervised polyp Dice (99.8%) suggests possible evaluation on training data.
  • No statistical significance testing is reported despite reporting variability (Table 2). This weakens claims of superiority where margins are modest (e.g., polyp tasks).
  • Methodological clarity gaps: (a) The NIG modeling treats class probabilities as Gaussian with an NIG prior (Sec. 2.1.2), but the derivation and validity of Var(NIG) = ω/(β(α−1)) in this context are not justified; conditions such as α>1 are not guaranteed or discussed. (b) The specific values, ranges, and sensitivity of τ1, τ2, κ, ζ1, ζ2, η1, η2, ε and the 3×3 neighborhood definition in 3D are not explored. (c) The SAF formula (Eq. 8) and the role of λk in combining masks lack precise implementation details and could be misinterpreted.
  • Sensitivity of EGS (Canny thresholds, n=6) is not studied; structural consistency based on edge overlap may be sensitive to edge detection parameters and image anisotropy.
  • Privacy claims are somewhat overstated: while no target-side learning reduces gradient leakage, the paper does not analyze potential privacy risks associated with diffusion-conditioned synthesis or storing synthesized images.

❓ Questions

  • Efficiency: Please report end-to-end wall-clock time and GPU memory for HEAL per case/volume on BraTS and per image on polyp tasks, including diffusion sampling (250 steps, n=6), and compare to SFUDA baselines with their adaptation times. How does performance vary with diffusion steps and n?
  • NIG denoising details: How are κ, ζ1, ζ2, η1, η2, ε chosen? How do you ensure α>1 (Eq. 5) and numerical stability? Please justify modeling class probabilities with a Gaussian + NIG prior and provide an ablation/sensitivity analysis of τ2 and the neighborhood size for E(v).
  • SAF implementation: Please clarify Eq. 8. Are Y_T^* and M_S(I_B) per-class probability maps or binary masks? How exactly are λk applied, and how is the final categorical prediction derived? Provide a toy example showing how SAF changes predictions when the smallest class is very small.
  • Polyp diffusion training: What diffusion model is used for 2D polyp datasets? Was a separate conditional diffusion model trained on the polyp source domain? Please provide training details analogous to Med-DDPM for BraTS.
  • Evaluation protocol: Did all baselines adapt and evaluate on the full target set (no split), consistent with HEAL? For supervised baselines, what train/val/test splits were used? The 99.8% Dice on Kvasir-SEG seems extremely high—please clarify the evaluation split and avoid training-on-test.
  • Statistical testing: Please provide paired statistical significance tests (e.g., Wilcoxon signed-rank) for Tables 1 and 2 and ablations, especially where improvements are modest or variances large.
  • Ablation and sensitivity: Please include sensitivity to τ1, τ2, Canny thresholds, and n; and an analysis of failure cases (e.g., when pseudo-labels are poor or when diffusion synthesis hallucinates structures).
  • t-SNE: What features are visualized (encoder layer, before/after certain blocks)? Are they extracted from M_S? Please quantify distribution alignment (e.g., MMD) to complement qualitative visuals.
  • Privacy: Can you discuss whether synthesized source-like images might inadvertently leak source-domain characteristics or, conversely, target-specific details? Any recommended handling or safeguards in deployment?

⚠️ Limitations

  • Reliance on initial pseudo-label quality: If the domain shift is large, entropy/NIG may prune too aggressively or insufficiently, propagating errors (also acknowledged in the paper’s limitations).
  • Computational burden: Diffusion-based synthesis (250 steps × n samples) may be heavy at scale; current claims of efficiency are unsubstantiated without runtime comparisons.
  • Method sensitivity: EGS (edge detection thresholds, number of samples) and HD (τ1, τ2, neighborhood size) may be sensitive; no robustness study is provided.
  • Theoretical grounding of NIG for class probabilities: Modeling probabilities with a Gaussian/NIG prior lacks derivation and could be replaced by distributions constrained to [0,1] (e.g., Beta), potentially impacting soundness.
  • Generalization: SAF is not applicable to single-class segmentation; extension to multi-organ, multi-class 3D settings beyond tumors is untested.
  • Potential negative societal impacts: In clinical contexts, diffusion-generated source-like images could be misinterpreted as real if stored or shared; failure modes may produce misleading structures, risking erroneous downstream decisions. Mitigations include clear labeling of synthetic images, auditing failure modes, and human-in-the-loop review.

🖼️ Image Evaluation

Cross-Modal Consistency: [36]/50

Textual Logical Soundness: [22]/30

Visual Aesthetics & Clarity: [15]/20

Overall Score: [73]/100

Detailed Evaluation (≤500 words):

1. Cross-Modal Consistency

• Minor 1: Visual ground truth

– Figure 1/(a–e): (a) Diffusion pre‑training pipeline; (b) nnUNet pre‑training; (c) HD pipeline with entropy→NIG→Var(NIG) mask; (d) EGS with Canny edges and S-score; (e) SAF fusing MS(IB) with YT*. Overall: end‑to‑end workflow from source pre‑training to target inference.

– Figure 2/(a–d): Bar charts (Dice) and line plots (ASD) for T1→T1ce and T2→FLAIR; configs Baseline/HD/HD+EGS/HEAL.

– Figure 3: Qualitative HD ablation per case: target image, No‑Adapt, entropy map, NIG uncertainty, HD‑refined.

– Figure 4/(a–b): t‑SNE showing Source, Source‑like, Target clusters.

• Major 1: Direction inconsistency. Sec. 3.3 mentions “FLAIR→T2” while the paper uses “T2→FLAIR.” Evidence: “Figure 2 (c)… in the FLAIR → T2 direction.”

• Major 2: Reported ASD values ambiguous vs figures/tables (e.g., “further diminishes ASD to 2.8 mm and 2.6 mm, respectively”). It’s unclear which classes/directions these refer to, and Table 1 lists mean ASD 2.0 and 2.6. Evidence: Sec 3.3 sentence with “2.8 mm and 2.6 mm.”

• Minor 2: Equation (1) text says P(v|c) but formula uses P(c|v).

• Minor 3: Figure 3 column labels (e.g., “T1”, “T1ce”) are not explained in caption; may confuse with direction.

2. Text Logic

• Major 1: “NIG” is referred to as Normal‑Inverse Gaussian, but equations and usage match the Normal‑Inverse‑Gamma prior. This affects the HD derivation and Var(NIG). Evidence: Sec 2.1.2 phrase “Normal-Inverse Gaussian (NIG)” with Eqs. (3–5).

• Minor 1: Missing/awkward punctuation in multiple numeric comparisons (e.g., “16.4% 25.7%”).

• Minor 2: “learning‑free” claim is consistent, but the diffusion model is used at target time; clarify no target‑time fine‑tuning anywhere.

3. Figure Quality

• Major 1: Several critical labels are tiny (Figure 1 icons/text “Reverse Diffusion Process,” “Model Frozen”; Figure 3 colorbars/labels). Risk of illegibility at print size. Evidence: Fig. 1 panels (c–e) dense pipelines with small annotations.

• Minor 1: Figure 2 bars/lines lack numeric labels; hard to verify stated deltas quickly.

• Minor 2: Figure 3 needs clearer column headers and a legend explaining heatmaps/uncertainty units.

Key strengths:

  • Clear end‑to‑end workflow and genuinely “learning‑free” target adaptation.
  • Strong quantitative gains; Table 1 supports SOTA among SFUDA for brain tumor; balanced discussion for polyp (best/second‑best).
  • Ablations and t‑SNE provide complementary evidence.

Key weaknesses:

  • Core probabilistic prior misnamed (Gaussian vs Gamma) and variance expression unclear.
  • Direction/metric wording inconsistencies and ambiguous ASD statements.
  • Overcrowded, small‑font annotations reduce figure self‑sufficiency (especially Fig. 3 and parts of Fig. 1).

Actionable suggestions:

  • Correct the NIG terminology/derivation, define parameters and the exact variance used.
  • Standardize direction names (always T2→FLAIR) and specify whether numbers are class‑wise or mean.
  • Add numeric labels to Fig. 2; enlarge critical text in Fig. 1/3; clarify Fig. 3 columns and add legends.

📊 Scores

Originality:3
Quality:2
Clarity:2
Significance:3
Soundness:2
Presentation:2
Contribution:3
Rating: 6

AI Review from SafeReviewer

SafeReviewer Review available after:
--d --h --m --s

📋 AI Review from SafeReviewer will be automatically processed

📋 Summary

This paper introduces HEAL, a novel Source-Free Unsupervised Domain Adaptation (SFUDA) framework for cross-modality medical image segmentation. The core contribution of HEAL lies in its 'learning-free' approach, which aims to adapt a pre-trained segmentation model to a target domain without any further training or fine-tuning. This is achieved through a combination of hierarchical denoising (HD), edge-guided selection (EGS), and size-aware fusion (SAF). The method begins by generating initial pseudo-labels for the target domain using the pre-trained model. HD then refines these pseudo-labels by leveraging both entropy and Normal-Inverse Gaussian (NIG) uncertainty maps to reduce noise. Subsequently, a diffusion model is employed to generate multiple source-like images conditioned on the refined pseudo-labels. EGS selects the most reliable generated image based on the structural consistency between the generated image and the pseudo-labels, measured using Canny edge detectors. Finally, SAF dynamically fuses the segmentation results from the selected generated image and the refined pseudo-labels, based on the size of the segmented objects. The authors evaluate HEAL on two medical image segmentation tasks: brain tumor segmentation using the BraTS 2021 dataset and polyp segmentation using the Kvasir-SEG and CVC-ClinicDB datasets. The experimental results demonstrate that HEAL outperforms several existing SFUDA methods, including No Adaptation, Supervised, ProtoContra, DPL, IAPC, and UPL, in terms of Dice score and Average Surface Distance (ASD). The paper emphasizes the computational efficiency and data privacy benefits of its learning-free approach, which avoids the need for additional training on the target domain. Overall, the paper presents a novel and effective approach to SFUDA for medical image segmentation, with a focus on practical applicability and efficiency.

✅ Strengths

I find several aspects of this paper to be commendable. The core idea of a 'learning-free' SFUDA method, which avoids further training on the target domain, is a significant strength. This approach not only enhances computational efficiency but also addresses data privacy concerns, making it particularly relevant for medical applications. The proposed framework, HEAL, integrates hierarchical denoising, edge-guided selection, and size-aware fusion in a novel way to achieve effective domain adaptation. The hierarchical denoising technique, which combines entropy and NIG uncertainty maps, is a clever approach to refine pseudo-labels and reduce error accumulation. The use of a diffusion model to generate source-like images conditioned on the refined pseudo-labels is also a notable innovation. The edge-guided selection mechanism, which selects the most reliable generated image based on structural consistency, is a well-reasoned approach to ensure the quality of the generated samples. The size-aware fusion technique, which dynamically fuses the segmentation results based on the size of the segmented objects, further enhances the performance of the method, particularly for small objects. The experimental results, which demonstrate that HEAL outperforms several existing SFUDA methods on both brain tumor and polyp segmentation tasks, provide strong evidence for the effectiveness of the proposed approach. The paper is also well-written and easy to follow, which makes it accessible to a wider audience. The authors have clearly articulated their methodology and have provided sufficient details for others to reproduce their results. The focus on practical applicability and efficiency is also a significant strength, as it makes the method more relevant for real-world medical applications.

❌ Weaknesses

Despite the strengths of this paper, I have identified several weaknesses that warrant further discussion. First, while the paper claims novelty in its approach, the individual components of HEAL, such as the use of diffusion models for image synthesis and the use of uncertainty maps for pseudo-label refinement, are not entirely novel in the broader field of machine learning. The novelty lies in the specific combination and application of these techniques within a SFUDA framework for medical image segmentation, particularly with the 'learning-free' characteristic. However, the paper could benefit from a more thorough discussion of how its specific implementation differs from existing uses of these techniques. Second, the paper lacks a comprehensive comparison with state-of-the-art methods. While the authors compare HEAL with several existing SFUDA methods, they do not include comparisons with more recent and potentially stronger baselines, such as methods based on large foundational models or more advanced diffusion model techniques. This omission makes it difficult to fully assess the relative performance of HEAL. Third, the paper does not provide a detailed analysis of the computational cost of HEAL. While the 'learning-free' characteristic suggests efficiency, the paper does not provide any quantitative analysis of the computational time or resources required for inference. This lack of information makes it difficult to evaluate the practical applicability of the method. Fourth, the paper lacks a dedicated 'Related Work' section. While the introduction and other sections touch upon related work, a dedicated section would provide a more comprehensive overview of the field and would better contextualize the contributions of HEAL. This omission also makes it difficult to fully assess the novelty of the proposed approach. Fifth, the paper does not provide sufficient details about the datasets used in the experiments. While the paper mentions the datasets used, it lacks specific details about the number of images/volumes, training/testing splits (for source domain), and image resolution. This lack of information makes it difficult to reproduce the results and to fully understand the experimental setup. Sixth, the paper does not provide a clear explanation of the 'source-like sample' (IB) selection process. While the paper explains that IB is selected based on the highest structural consistency metric Si, it does not explicitly state that this is a selection process from the n generated samples. This lack of clarity could lead to confusion. Seventh, the paper lacks a detailed explanation of the size-aware fusion mechanism. While the paper explains that SAF dynamically selects the most reliable source based on the size of the segmentation targets, it does not provide a detailed explanation of how this is achieved. The paper also does not provide a clear justification for why fusing the categories with the smallest proportion of voxels in Y* is the correct approach. Eighth, the paper does not provide a detailed analysis of the limitations of HEAL. While the paper briefly mentions limitations in the conclusion, it does not provide a thorough discussion of potential failure cases or scenarios where the method might not perform well. Finally, the paper does not provide a detailed explanation of how the Normal-Inverse Gaussian (NIG) distribution is used for pseudo-label denoising. While the paper provides the formulas for calculating the NIG parameters, it does not provide a clear explanation of how the NIG distribution is used to refine the pseudo-labels. This lack of explanation makes it difficult to fully understand the denoising process.

💡 Suggestions

To address the identified weaknesses, I recommend several concrete improvements. First, the authors should include a more thorough discussion of the novelty of their approach, specifically highlighting how their implementation of the individual components of HEAL differs from existing uses of these techniques. This discussion should be included in the introduction and method sections. Second, the authors should include a more comprehensive comparison with state-of-the-art methods, including methods based on large foundational models and more advanced diffusion model techniques. This comparison should be included in the experimental results section. Third, the authors should provide a detailed analysis of the computational cost of HEAL, including the computational time and resources required for inference. This analysis should be included in the experimental results section. Fourth, the authors should include a dedicated 'Related Work' section that provides a comprehensive overview of the field and contextualizes the contributions of HEAL. This section should be placed after the introduction. Fifth, the authors should provide more detailed information about the datasets used in the experiments, including the number of images/volumes, training/testing splits (for source domain), and image resolution. This information should be included in the experimental setup section. Sixth, the authors should provide a clearer explanation of the 'source-like sample' (IB) selection process, explicitly stating that IB is selected from the n generated samples based on the highest structural consistency metric Si. This explanation should be included in the method section. Seventh, the authors should provide a more detailed explanation of the size-aware fusion mechanism, including a clear justification for why fusing the categories with the smallest proportion of voxels in Y* is the correct approach. This explanation should be included in the method section. Eighth, the authors should provide a more detailed analysis of the limitations of HEAL, including potential failure cases or scenarios where the method might not perform well. This analysis should be included in the conclusion section. Finally, the authors should provide a more detailed explanation of how the Normal-Inverse Gaussian (NIG) distribution is used for pseudo-label denoising, including a clear explanation of how the NIG distribution is used to refine the pseudo-labels. This explanation should be included in the method section. In addition to these specific suggestions, I also recommend that the authors carefully review the writing of the paper to ensure that it is clear, concise, and easy to understand. The paper should also be carefully proofread to eliminate any typos or grammatical errors.

❓ Questions

I have several questions that arise from my analysis of this paper. First, how does the performance of HEAL compare to methods that use large foundational models for medical image segmentation, particularly in terms of both accuracy and computational cost? Second, what is the sensitivity of HEAL to the choice of hyperparameters, such as the entropy threshold and the number of generated samples? Third, how does the performance of HEAL vary across different medical imaging modalities and datasets? Fourth, what are the specific scenarios or types of images where HEAL is most likely to fail, and what are the potential reasons for these failures? Fifth, how does the choice of the diffusion model architecture affect the performance of HEAL, and what are the trade-offs between different diffusion model architectures in terms of both accuracy and computational cost? Sixth, how does the size-aware fusion mechanism handle cases where the size of the segmented objects varies significantly within the same image? Seventh, what is the impact of the quality of the initial pseudo-labels on the overall performance of HEAL, and how can the quality of these pseudo-labels be improved? Eighth, how does the computational cost of HEAL scale with the size of the input images and the number of segmented objects? Finally, what are the ethical implications of using a 'learning-free' approach for medical image segmentation, particularly in terms of data privacy and algorithmic bias?

📊 Scores

Soundness:2.25
Presentation:2.5
Contribution:2.0
Rating: 4.0

Keywords

Click the button to extract keywords

Insights

Click the button to extract insights
Version Management
Version 1
Citation Tools

📝 Cite This Paper